SCHEMBL12912475

SCHEMBL12912475

Cc1ccc2c(c1)nc(-c1ccccc1)n2-c1ccc(-c2ccc3ccc4cccc5ccc2c3c45)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 1/20 0.47
▸ PDE10A Q9Y233 4/20 0.45
▸ SIRT2 Q8IXJ6 2/20 0.44
▸ SIRT1 Q96EB6 2/20 0.44
▸ ESR1 P03372 1/20 0.43
▸ ESR2 Q92731 1/20 0.43
▸ ALDH1A1 P00352 6/20 0.41
▸ DHFR P00374 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ PTGER4 P35408 1/20 0.38
▸ GRIA1 P42261 1/20 0.37
▸ CACNG8 Q8WXS5 1/20 0.37
▸ CACNG2 Q9Y698 1/20 0.37
▸ MAPT P10636 3/20 0.37
▸ TP53 P04637 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12912460 0.92 ESR1 (0.45) NLRP3PDE10ASIRT2SIRT1ESR1
SCHEMBL12912538 0.91 ESR1 (0.44) NLRP3PDE10ASIRT2SIRT1ESR1
SCHEMBL12912505 0.89 ESR1 (0.43) NLRP3SIRT2SIRT1ESR1ESR2
SCHEMBL12912527 0.89 SIRT2 (0.43) NLRP3PDE10ASIRT2SIRT1ESR1
SCHEMBL9976943 0.89 ESR1 (0.43) NLRP3PDE10ASIRT2SIRT1ESR1
SCHEMBL12912496 0.89 ESR1 (0.39) PDE10ASIRT2SIRT1ESR1ESR2
SCHEMBL12912474 0.88 GRIA1 (0.46) SIRT2SIRT1ESR1ESR2ALDH1A1
SCHEMBL12912502 0.88 ESR1 (0.42) NLRP3PDE10ASIRT2SIRT1ESR1
SCHEMBL12912522 0.88 ESR1 (0.42) NLRP3PDE10ASIRT2SIRT1ESR1
SCHEMBL12912510 0.88 ESR1 (0.42) NLRP3SIRT2SIRT1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8945724-B2 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same IDEMITSU KOSAN CO., LTD. (JP) 2015-02-03 — — US disclosed
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME NUDC, TYR, NUDT1 NLRP3 58/4885PDE10A 1569/4885SIRT2 942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback